Effect of Feru-guard 100M on the progression prevention of mild cognitive impairment associated - Effect of Feru-guard

Glovia Co., Ltd.0 个研究点目标入组 140 人开始时间: 2016年9月15日最近更新: 2023年10月17日

适应症

试验速览

暂无简介。

•1. Patients who have merged the neurodegenerative disease which presents a dementia-like symptoms, or there is a suspicion Parkinson's disease, Huntington's disease, Down's syndrome, Creutzfeldt-Jakob disease, progressive supranuclear palsy, cortical basal degeneration, etc. 2. patient suspected failure in cognitive function due to causes of the following Vascular dementia, metabolic diseases (hypothyroidism, vitamin B12 hypothyroidism, folic acid deficiency, etc.), head trauma, normal pressure hydrocephalus 3. Patients with delirium due to drug addiction Patients 4. there is a history of the following disease onset before Alcoholism, stroke, depression, manic state, schizophrenia 5. malignant neoplasm, patients with acute inflammatory disease 6. Patients have experience taking Feru-guard in the past 7. Patients have medication anti-dementia drugs 8. CDR-J 1 or more 9. HbA1c 8.0 or higher 10. If clear metabolic syndrome 11. Other 12. If the principal investigator or researcher has determined that improper participation in the present study

发起方